Pharmaceuticals, health and wellness

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report fkansteiner Wed, 03/16/2022 – 13:19 Source link

AbbVie, Eli Lilly, Novartis and more cut back in Russia amid corporate exodus over Ukraine war aliu Wed, 03/16/2022 – 11:18 Source link

Lilly and Boehringer’s Jardiance, trailing AZ’s Farxiga in chronic kidney disease, posts early efficacy win fkansteiner Wed, 03/16/2022 – 10:27 Source link

Former J&J CEO Alex Gorsky saw total pay fall last year but remains among pharma’s best-paid esagonowsky Wed, 03/16/2022 – 10:27 Source link

Biotech execs who pinched Genentech trade secrets headed to prison fkansteiner Wed, 03/16/2022 – 09:27 Source link

Viatris’ copycat to AstraZeneca blockbuster Symbicort passes FDA muster, but legal battle delays launch esagonowsky Wed, 03/16/2022 – 08:46 Source link

Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month data esagonowsky Tue, 03/15/2022 – 13:43 Source link

In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer aliu Tue, 03/15/2022 – 11:04 Source link

High-risk lung cancer patients aren’t getting screened, survey shows. What can the industry do? mwen Tue, 03/15/2022 – 10:58 Source link

After trial flop, Exelixis drops plan to pair Cabometyx with Roche’s Tecentriq in early-stage liver cancer fkansteiner Tue, 03/15/2022 – 10:16 Source link

Progenity starts oral biologic trial in ulcerative colitis after coming through early clinical test ntaylor Tue, 03/15/2022 – 09:53 Source link

MHRA request about ultrasound activation system holds up Exact Therapeutics’ solid tumor trial   ntaylor Tue, 03/15/2022 – 09:42 Source link